Literature DB >> 12574934

Botulinum toxin type A (Dysport) for the treatment of Zenker's diverticulum.

P Spinelli1, G Ballardini.   

Abstract

The standard treatment for Zenker's diverticulum (ZD) is surgical, but transendoscopic section of the diverticular spur has also been performed with good results. We treated two patients with the injection of 300-350 IU of botulinum toxin type A (Dysport) into the diverticular spur. Both patients were dysphagic because of a large ZD. A few hours after the treatment, the patients were able to return to a normal, nonrestricted diet. They remain symptom-free 12 and 3 months later, respectively. No complications have been observed. As a result of its ease of application and efficacy, this treatment can be recommended for patients who are unable to undergo the surgical operations; it can be considered a valid alternative to the other endoscopic procedures.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574934     DOI: 10.1007/s00464-002-4247-9

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  3 in total

Review 1.  [Botulinum toxin treatment in the head and neck region: current aspects, developments, and problems].

Authors:  R Laskawi
Journal:  HNO       Date:  2007-06       Impact factor: 1.284

Review 2.  Endoscopic stapling of Zenker's diverticulum: establishing national baselines for auditing clinical outcomes in the United Kingdom.

Authors:  Samuel C Leong; Mark D Wilkie; Christopher J Webb
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-02-17       Impact factor: 2.503

3.  Dysphagia.

Authors:  Dawn D. F. Ferguson; Kenneth R. DeVault
Journal:  Curr Treat Options Gastroenterol       Date:  2004-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.